The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.

National Drug Take Back Day is Saturday, Oct. 25, 2025.Check with your local police department to find the closest drop-off box near you or find one online here.About National Drug Take Back DayUnused ...

The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea, according to a European clinical study in which the University of ...

Geneva -- The World Health Organization sounded the alarm Monday over soaring numbers of drug-resistant bacterial infections, compromising the effectiveness of life-saving treatments and rendering ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. A troubled Indiana ...

Nimacimab, a new type of anti-obesity drug with a different mode of action – it targets the body’s endocannabinoid system – has shown promising results in a Phase 2a clinical trial, significantly ...

A Columbus man was sentenced to 112 to 117½ years in prison for running a drug trafficking organization. Troy Locke, 40, was convicted on over a dozen charges, including selling fentanyl, cocaine, and ...

As the president and CEO of Ascendiun, the nonprofit parent company of Blue Shield of California — one of California’s largest health insurers — I believe that all health care decision-making should ...

The STEP UP trials revealed that a 7.2 mg dose of semaglutide led to greater weight loss than the currently approved 2.4 mg dose. Nearly half of participants lost 20% or more of their body weight, ...

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety. Credit...Blake Cale Supported by By Walt Bogdanich Carson Kessler ...

Colorado became the first state in the country Friday to set a maximum price that insurers and patients can pay for a prescription medication — a move that’s likely to face lawsuits. The state’s ...

An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom ...